Frontlight ResearchEarly access
Trial site
San Miguel de Tucumán
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- High blood pressure1 trial
- Metastatic breast cancer1 trial
- Obesity1 trial
- Type 1 diabetes1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 32 trials
- Phase 1/21 trial
- Status
- Active, not recruiting2 trials
- Recruiting1 trial
- Lead sponsor
- Alnylam Pharmaceuticals2 trials
- Olema Pharmaceuticals, Inc.1 trial
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure1 recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026